Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Global Bipolar Disorder Treatment Market Growth 2023-2029
... CAGR of % from 2023 to 2029. United States market for Bipolar Disorder Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Global Tardive Dyskinesia Treatment Market 2024-2028
... tardive dyskinesia treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Contract Pharmaceutical Dose Manufacturing Industry - Composition, Size, Market Share and Outlook, 2023 Edition
... of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier ... Read More
-
Global Proton Pump Inhibitors (PPIs) Market 2024-2028
... on the proton pump inhibitors (PPIs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Orodispersible Tablets Market, By Drug Class (Analgesics, Antiemetics, Antipsychotics, Anti-inflammatory Drugs, Sedatives/Hypnotics, Antihypertensives, Others), By Disease Indication (Central Nervous System Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Respiratory Disorders, Allergy and Asthma, Others), By Age Group (Pediatric Patients, Adult Patients, Geriatric Patients), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Patients, Adult Patients, Geriatric Patients), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Orodispersible tablets (ODTs) are solid unit dosage ... Read More
-
Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 18.0 Billion by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2022-2028. Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. ... Read More
-
Genitourinary Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 37.0 Billion by 2028, exhibiting a growth rate (CAGR) of 2.2% during 2022-2028. The genitourinary system includes kidneys, ureters, bladder, urethra, and genital organs, which play a vital role in reproduction and getting rid of ... Read More
-
Hyperlipidemia Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 25.2 Billion by 2028, exhibiting a growth rate (CAGR) of 2.1% during 2022-2028. Hyperlipidemia, or high cholesterol, refers to a medical ailment characterized by high levels of fats in the bloodstream. It is the abnormal ... Read More
-
Osteoporosis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 21.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2022-2028. Osteoporosis is a disease that causes deterioration of bone tissues and strength. It is diagnosed by performing different scans, such as X-ray, ... Read More
-
Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 15.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2022-2028. Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy refers to the non-cancerous enlargement of the prostate gland that ... Read More
-
Pharmacovigilance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2022-2028. Pharmacovigilance (PV) is the pharmacological science concerning the detection, assessment, understanding and prevention of unfavorable effects with pharmaceutical products. It plays a pivotal role ... Read More
-
SOLIRIS Drug Insight and Market Forecast − 2032
... of the SOLIRIS for PNH in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report ... Read More
-
INVELTYS Drug Insight and Market Forecast − 2032
... the INVELTYS for acute ocular pain in the United States for the study period 2019 –2032 is provided in this report along with a detailed description of the INVELTYS for acute ocular pain. The report ... Read More
-
EMPAVELI Drug Insight and Market Forecast − 2032
... of the EMPAVELI for PNH in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report ... Read More
-
VXA-A1.1 Emerging Drug Insight and Market Forecast − 2032
... of the VXA-A1.1 for seasonal influenza in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
FLUARIX QUADRIVALENT Drug Insight and Market Forecast − 2032
... picture of the FLUARIX QUADRIVALENT for seasonal influenza in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 –2032 is provided in this ... Read More
-
DNX-2401 Emerging Drug Insight and Market Forecast − 2032
... picture of the DNX-2401 for GBM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Danicopan Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the danicopan for PNH in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in ... Read More
-
FLUMIST QUADRIVALENT Drug Insight and Market Forecast − 2032
... picture of the FLUMIST QUADRIVALENT for seasonal influenza in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 –2032 is provided in this ... Read More
-
Quadrivalent VLP vaccine Emerging Drug Insight and Market Forecast − 2032
... seven major markets. A detailed picture of the quadrivalent VLP vaccine for seasonal influenza in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the ... Read More
-
NanoFlu Emerging Drug Insight and Market Forecast − 2032
... of the NanoFlu for seasonal influenza in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
DEXTENZA Drug Insight and Market Forecast − 2032
... the DEXTENZA for acute ocular pain in the United States for the study period 2019 –2032 is provided in this report along with a detailed description of the DEXTENZA for acute ocular pain. The report ... Read More
-
OCS-01 Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the OCS-01 for acute ocular pain in the 8MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Canada and South Korea for the study period 2019 ... Read More
-
APP13007 Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the APP13007 for acute ocular pain in the 8MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Canada and South Korea for the study period 2019 ... Read More
-
Crovalimab Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the crovalimab for PNH in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in ... Read More
Research Assistance
